1
|
Smets G, Gutermuth J, Grosber M, Baharlou S. Pulsed dye laser for facial erythema in Netherton syndrome. J Eur Acad Dermatol Venereol 2024; 38:e229-e230. [PMID: 37793828 DOI: 10.1111/jdv.19547] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Accepted: 09/26/2023] [Indexed: 10/06/2023]
Affiliation(s)
- G Smets
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - J Gutermuth
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - M Grosber
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - S Baharlou
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| |
Collapse
|
2
|
De Brucker L, Seyler L, Leemans G, Gutermuth J, Grosber M. Acute generalized exanthematous pustulosis (AGEP) in a patient with COVID-19 infection. J Eur Acad Dermatol Venereol 2023. [PMID: 37060256 DOI: 10.1111/jdv.19119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Accepted: 04/07/2023] [Indexed: 04/16/2023]
Affiliation(s)
- L De Brucker
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Brussels, Belgium
| | - L Seyler
- Department of Infectious Diseases, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Brussels, Belgium
| | - G Leemans
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Brussels, Belgium
- Department of Pathology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Brussels, Belgium
| | - J Gutermuth
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Brussels, Belgium
| | - M Grosber
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Jette, Brussels, Belgium
| |
Collapse
|
3
|
Jadoul A, Huygen L, Leemans G, Grosber M, Kortekaas Krohn I, Gutermuth J. JAK1/2 pathway-specific treatment of disseminated granuloma annulare with baricitinib. J Eur Acad Dermatol Venereol 2023. [PMID: 36974587 DOI: 10.1111/jdv.19073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2022] [Accepted: 03/21/2023] [Indexed: 03/29/2023]
Affiliation(s)
- A Jadoul
- Vrije Universiteit Brussel (VUB), SKIN Research Group, Laarbeeklaan 103, 1090, Brussels, Belgium
- Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Dermatology, Laarbeeklaan 101, 1090, Brussels, Belgium
| | - L Huygen
- Vrije Universiteit Brussel (VUB), SKIN Research Group, Laarbeeklaan 103, 1090, Brussels, Belgium
- Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Dermatology, Laarbeeklaan 101, 1090, Brussels, Belgium
| | - G Leemans
- Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Dermatology, Laarbeeklaan 101, 1090, Brussels, Belgium
- Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Pathology, Laarbeeklaan 101, 1090, Brussels, Belgium
| | - M Grosber
- Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Dermatology, Laarbeeklaan 101, 1090, Brussels, Belgium
| | - I Kortekaas Krohn
- Vrije Universiteit Brussel (VUB), SKIN Research Group, Laarbeeklaan 103, 1090, Brussels, Belgium
- Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Dermatology, Laarbeeklaan 101, 1090, Brussels, Belgium
| | - J Gutermuth
- Vrije Universiteit Brussel (VUB), SKIN Research Group, Laarbeeklaan 103, 1090, Brussels, Belgium
- Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Department of Dermatology, Laarbeeklaan 101, 1090, Brussels, Belgium
| |
Collapse
|
4
|
Nguyen S, Van de Perre E, Velkeniers B, Pierret L, Gutermuth J, Grosber M. Resolution of idiopathic erythema gyratum repens with acitretin. J Eur Acad Dermatol Venereol 2021; 36:e300-e302. [PMID: 34863008 DOI: 10.1111/jdv.17851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- S Nguyen
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - E Van de Perre
- Department of Nephrology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - B Velkeniers
- Department of Endocrinology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - L Pierret
- Dr. Pierret Dermatoloog Dworp, Dworp, Belgium
| | - J Gutermuth
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - M Grosber
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| |
Collapse
|
5
|
Smets G, Grosber M, Gutermuth J, Bravenboer B, Velkeniers B. Mesalazine-induced eosinophilic glossitis and hypereosinophilia in a patient with ulcerative colitis: a case report and review of literature. J Eur Acad Dermatol Venereol 2021; 35:e462-e464. [PMID: 33725368 DOI: 10.1111/jdv.17223] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Revised: 02/04/2021] [Accepted: 03/08/2021] [Indexed: 11/30/2022]
Affiliation(s)
- G Smets
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - M Grosber
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - J Gutermuth
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - B Bravenboer
- Department of Internal Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| | - B Velkeniers
- Department of Internal Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium
| |
Collapse
|
6
|
Reynaert V, Grosber M, Tache A, Mana F, Buydens P, Lacor P, Gutermuth J. Oral tuberculosis in a patient with Crohn's disease on TNF-α blockers. J Eur Acad Dermatol Venereol 2020; 35:e236-e237. [PMID: 32977350 DOI: 10.1111/jdv.16961] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- V Reynaert
- Department of Dermatology, Universitair Ziekenhuis Brussel (UZB), Brussels, Belgium.,Department of Dermatology, Vrije Universiteit Brussel (VUB), Brussels, Belgium
| | - M Grosber
- Department of Dermatology, Universitair Ziekenhuis Brussel (UZB), Brussels, Belgium
| | - A Tache
- European Face Centre, Cleft & Craniofacial Team, Universitair Ziekenhuis Brussel (UZB), Brussels, Belgium
| | - F Mana
- Department of Gastro-enterology, Saint-Jean Clinic, Brussels, Belgium
| | - P Buydens
- Department of Gastro-enterology, Universitair Ziekenhuis Brussel (UZB), Brussels, Belgium
| | - P Lacor
- Department of Internal Medicine, Universitair Ziekenhuis Brussel (UZB), Brussels, Belgium
| | - J Gutermuth
- Department of Dermatology, Universitair Ziekenhuis Brussel (UZB), Brussels, Belgium.,Department of Dermatology, Vrije Universiteit Brussel (VUB), Brussels, Belgium
| |
Collapse
|
7
|
Verheyden M, Grosber M, Gutermuth J, Velkeniers B. Relapsing symmetric livedo reticularis in a patient with COVID-19 infection. J Eur Acad Dermatol Venereol 2020; 34:e684-e686. [PMID: 32588475 PMCID: PMC7361321 DOI: 10.1111/jdv.16773] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Accepted: 06/15/2020] [Indexed: 01/25/2023]
Affiliation(s)
- M Verheyden
- Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Jette, Brussels, Belgium
| | - M Grosber
- Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Jette, Brussels, Belgium
| | - J Gutermuth
- Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Jette, Brussels, Belgium
| | - B Velkeniers
- Department of Internal Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Jette, Brussels, Belgium
| |
Collapse
|
8
|
Van Tendeloo E, Gutermuth J, Grosber M. Positive patch testing with omeprazole in Stevens‐Johnson syndrome: a case report. J Eur Acad Dermatol Venereol 2020; 35:e74-e75. [DOI: 10.1111/jdv.16814] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- E. Van Tendeloo
- Department of Dermatology Universitair Ziekenhuis BrusselVrije Universiteit Brussel (VUB) Brussels Belgium
| | - J. Gutermuth
- Department of Dermatology Universitair Ziekenhuis BrusselVrije Universiteit Brussel (VUB) Brussels Belgium
| | - M. Grosber
- Department of Dermatology Universitair Ziekenhuis BrusselVrije Universiteit Brussel (VUB) Brussels Belgium
| |
Collapse
|
9
|
Lapeere H, Baeck M, Stockman A, Sabato V, Grosber M, Moutschen M, Lambert J, Vandebuerie L, de Montjoye L, Rabijns H, Allewaert K, Schrijvers R. A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium. J Eur Acad Dermatol Venereol 2019; 34:127-134. [PMID: 31099916 PMCID: PMC7003755 DOI: 10.1111/jdv.15684] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2019] [Accepted: 04/23/2019] [Indexed: 01/17/2023]
Abstract
Background Chronic spontaneous urticaria (CSU) is characterized by the repeated occurrence of persistent hives and/or angioedema for ≥6 weeks, without specific external stimuli. H1‐antihistamines have long been the standard of care of CSU, but many patients remain uncontrolled even at 4× the approved dose. Add‐on therapy with omalizumab has proven effective in clinical trials, but little is known about omalizumab treatment in Belgium. Objective To collect real‐world clinical data on omalizumab treatment in adults with CSU in Belgium. Methods This was an observational, retrospective chart review of adults with CSU, who initiated omalizumab treatment between August 2014 and December 2016 (maximum 28 months follow‐up). Results In total, 235 patients were included (median time from symptom onset to diagnosis, 5.4 months; median time from diagnosis to commencing omalizumab, 6.7 months). Treatments used before/after commencing omalizumab did not always adhere to guidelines; many patients (26.4%/11.1%) received first‐generation H1‐antihistamines, while 20.4% used omalizumab monotherapy after initiating treatment. The mean interval between omalizumab administrations was 4.8 (SD 1.7) weeks; 67.8% of patients had ≥1 interval prolongation and/or shortening. Mean baseline 7‐day Urticaria Activity Score (UAS7) was 32.0 (SD 6.05); this improved to 12.6 (SD 11.2) after 1 month of omalizumab. About 67.2% of patients reached UAS7 ≤ 6 (well controlled) during the study. A total of 87 patients stopped omalizumab and never restarted before the end of the observation period; the most prevalent reason was remission of symptoms (49.4% of patients), followed by lack of effect (12.6%), lost to follow‐up (6.9%) and adverse events (3.4%). Headache was the most common adverse event (n = 8/82). No anaphylaxis was reported. Conclusions This study revealed that patients initiated on omalizumab in Belgium had severe CSU at baseline, and showed substantial improvements after 1 month of treatment. Greater adherence to the prescription of guideline‐recommended medications is needed for the treatment of CSU.
Collapse
Affiliation(s)
- H Lapeere
- Department of Dermatology, Ghent University Hospital, Gent, Belgium
| | - M Baeck
- Department of Dermatology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| | - A Stockman
- Department of Dermatology, AZ Delta Campus Rembert Torhout, Torhout, Belgium
| | - V Sabato
- Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium
| | - M Grosber
- Department of Dermatology, Universitair Ziekenhuis Brussel, Brussels, Belgium.,Vrije Universiteit Brussel, Brussels, Belgium
| | - M Moutschen
- Service Infectious Diseases and General Internal Medicine, CHU Liège, Liège, Belgium
| | - J Lambert
- Department of Dermatology University Hospital Antwerp, University of Antwerp, Antwerp, Belgium
| | - L Vandebuerie
- Groepspraktijk Dermatologie Roeselare, Roeselare, Belgium
| | - L de Montjoye
- Department of Dermatology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| | - H Rabijns
- N.V. Novartis Pharma S.A., Vilvoorde, Belgium
| | - K Allewaert
- N.V. Novartis Pharma S.A., Vilvoorde, Belgium
| | - R Schrijvers
- Laboratory of Clinical Immunology, KU Leuven Department of Microbiology and Immunology, Leuven, Belgium
| |
Collapse
|
10
|
Clarysse K, Grosber M, Ring J, Gutermuth J, Kivlahan C. Skin lesions, differential diagnosis and practical approach to potential survivors of torture. J Eur Acad Dermatol Venereol 2019; 33:1232-1240. [PMID: 30659672 DOI: 10.1111/jdv.15439] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2018] [Accepted: 12/03/2018] [Indexed: 11/29/2022]
Abstract
As the international refugee crisis has reached new proportions (BMJ, 355, 2016 and i5412), survivors of torture increasingly present in treating physicians with an array of acute or chronic skin lesions. Physicians should be aware of common presentations and likely differential diagnoses in order to avoid mislabelling or under-recognizing torture. Survivors of torture also frequently suffer from psychological sequelae, such as post-traumatic stress disorder, and appropriate referrals are essential in order to improve recovery trajectory. Skin sequelae are the most common physical findings of torture. Not all skin lesions seen in tortured survivors are due to perpetrator inflicted injuries, and many dermatological conditions can mimic lesions typical of torture, as can scars as a result of folk remedies or cultural practices specific to geographical regions. Medical documentation of torture includes injury and lesion description. While forensic dermatology and other forensic specialties use an injury description taxonomy, and the standard dermatologic taxonomy uses an anatomic description, they are complementary sciences for lesions inflicted by torture. This results in an opportunity for learning across disciplines in order to improve evidence documentation for survivors of torture. This article describes features of common skin lesions consistent with torture, including their clinical appearances, differential diagnoses, patterns of injury and appropriate clinical descriptions.
Collapse
Affiliation(s)
- K Clarysse
- Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
| | - M Grosber
- Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
| | - J Ring
- Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Klinikum rechts der Isar, Technische Universität München, München, Germany
| | - J Gutermuth
- Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium
| | - C Kivlahan
- University of California San Francisco Health System, San Francisco, CA, USA
| |
Collapse
|
11
|
Seghers AK, Grosber M, Urbain D, Mana F. Cheilitis granulomatosa and Crohn's disease : a case report. Acta Gastroenterol Belg 2019; 82:326-328. [PMID: 31314197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
In this case report we describe the evolution of Cheilitis granulomatosa (GC) in a young patient with Crohn's disease during treatment with anti-TNF-alfa therapy.
Collapse
Affiliation(s)
- A-K Seghers
- Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Departement of Gastro-Enterology, Laarbeeklaan 101, 1090 Brussels, Belgium
| | - M Grosber
- Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Departement of Gastro-Enterology, Laarbeeklaan 101, 1090 Brussels, Belgium
| | - D Urbain
- Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Departement of Gastro-Enterology, Laarbeeklaan 101, 1090 Brussels, Belgium
| | - F Mana
- Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Departement of Gastro-Enterology, Laarbeeklaan 101, 1090 Brussels, Belgium
| |
Collapse
|
12
|
Krygier J, Leemans G, Forsyth R, de Becker A, Gutermuth J, Grosber M. Un nouveau cas d’éruption de type pityriasis rubra pilaire associée à l’inhibiteur de tyrosine kinase ponatinib. Ann Dermatol Venereol 2018; 145:665-670. [DOI: 10.1016/j.annder.2018.04.009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2017] [Revised: 01/22/2018] [Accepted: 04/19/2018] [Indexed: 10/14/2022]
|
13
|
Mostmans Y, Grosber M, De Coninck A, Peeters V, Ring J, Gutermuth J. Paraneoplastic systemic lupus erythematosus in association with oat cell tumour of the lung. J Eur Acad Dermatol Venereol 2017; 32:e25-e26. [PMID: 28707716 DOI: 10.1111/jdv.14473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Y Mostmans
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium
| | - M Grosber
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium
| | - A De Coninck
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium
| | - V Peeters
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium
| | - J Ring
- Department of Dermatology and Allergology Biederstein, Technical University Munich (TUM), Arcisstraße 21, D-80333, Munich, Germany.,Christine Kühne Center for Allergy Research and Education (CK-CARE), Herman-Burchard-Strasse 1, 7265, Davos, Switzerland
| | - J Gutermuth
- Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium
| |
Collapse
|
14
|
Mostmans Y, Grosber M, Blykers M, Mols P, Naeije N, Gutermuth J. Adrenaline in anaphylaxis treatment and self-administration: experience from an inner city emergency department. Allergy 2017; 72:492-497. [PMID: 27709624 DOI: 10.1111/all.13060] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/03/2016] [Indexed: 01/17/2023]
Abstract
BACKGROUND Anaphylaxis is a life-threatening emergency of which reliable epidemiological data are lacking. This study aimed to analyze how quickly patients presenting with anaphylaxis were treated in emergency and whether treatment followed the European Academy of Allergy and Clinical Immunology (EAACI) guidelines. METHODS Patient data were collected between April 2009 and April 2013. Emergency doctors completed a questionnaire for adult patients presenting at the emergency department (ED) of the St. Pierre hospital in Brussels with anaphylaxis. Inclusion criteria were based on the Sampson criteria of anaphylaxis. Data were analyzed using a Microsoft Excel database. RESULTS About 0.04% (100/230878) of all emergency visits in adults presented with anaphylaxis. 64% of patients received their first medical help later than 30 min after symptom onset. 67% of patients received adrenaline, 85% oral antihistamines, and 89% received IV glucocorticosteroids. 46/100 patients were discharged directly from the ED, of which 87% received further medical prescriptions for self-administration: 67% corticosteroids, 83% antihistamines, and 9% intramuscular adrenaline. 74% were instructed to consult an allergologist for adequate diagnosis. 54/100 patients were hospitalized. CONCLUSION The majority of patients were treated according to the EAACI guidelines for management of anaphylaxis, but only a minority received the recommended adrenaline auto-injector for self-administration at discharge. Because the majority of patients received medical help later than 30 min after symptom onset, adrenaline auto-injector prescription is a necessity. The low rate of doctors prescribing adrenaline auto-injectors in the ED setting underlines the need to train doctors of various backgrounds in prevention and treatment of anaphylaxis and the close collaboration with allergologists.
Collapse
Affiliation(s)
- Y. Mostmans
- Department of Dermatology; Universitary Hospital Brussels (UZ Brussel), Vrije Universiteit Brussel (VUB); Laarbeeklaan 101; 1090 Brussels Belgium
| | - M. Grosber
- Department of Dermatology; Universitary Hospital Brussels (UZ Brussel), Vrije Universiteit Brussel (VUB); Laarbeeklaan 101; 1090 Brussels Belgium
| | - M. Blykers
- Department of Dermatology; Universitary Hospital Brussels (UZ Brussel), Vrije Universiteit Brussel (VUB); Laarbeeklaan 101; 1090 Brussels Belgium
| | - P. Mols
- Service des Urgences et du SMUR; C.H.U. Saint-Pierre; Brussels Belgium
| | - N. Naeije
- Clinic of Immuno-allergology; C.H.U. Brugmann; Brussels Belgium
| | - J. Gutermuth
- Department of Dermatology; Universitary Hospital Brussels (UZ Brussel), Vrije Universiteit Brussel (VUB); Laarbeeklaan 101; 1090 Brussels Belgium
| |
Collapse
|
15
|
Brockow K, Aberer W, Atanaskovic-Markovic M, Bavbek S, Bircher A, Bilo B, Blanca M, Bonadonna P, Burbach G, Calogiuri G, Caruso C, Celik G, Cernadas J, Chiriac A, Demoly P, Oude Elberink JNG, Fernandez J, Gomes E, Garvey LH, Gooi J, Gotua M, Grosber M, Kauppi P, Kvedariene V, Laguna JJ, Makowska J, Mosbech H, Nakonechna A, Papadopolous NG, Ring J, Romano A, Rockmann H, Sargur R, Sedlackova L, Sigurdardottir S, Schnyder B, Storaas T, Torres M, Zidarn M, Terreehorst I. Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper. Allergy 2016; 71:1533-1539. [PMID: 27145347 DOI: 10.1111/all.12929] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/02/2016] [Indexed: 12/27/2022]
Abstract
The strongest and best-documented risk factor for drug hypersensitivity (DH) is the history of a previous reaction. Accidental exposures to drugs may lead to severe or even fatal reactions in sensitized patients. Preventable prescription errors are common. They are often due to inadequate medical history or poor risk assessment of recurrence of drug reaction. Proper documentation is essential information for the doctor to make sound therapeutic decision. The European Network on Drug Allergy and Drug Allergy Interest Group of the European Academy of Allergy and Clinical Immunology have formed a task force and developed a drug allergy passport as well as general guidelines of drug allergy documentation. A drug allergy passport, a drug allergy alert card, a certificate, and a discharge letter after medical evaluation are adequate means to document DH in a patient. They are to be handed to the patient who is advised to carry the documentation at all times especially when away from home. A drug allergy passport should at least contain information on the culprit drug(s) including international nonproprietary name, clinical manifestations including severity, diagnostic measures, potential cross-reactivity, alternative drugs to prescribe, and where more detailed information can be obtained from the issuer. It should be given to patients only after full allergy workup. In the future, electronic prescription systems with alert functions will become more common and should include the same information as in paper-based documentation.
Collapse
|
16
|
Abstract
OBJECTIVES Anaphylaxis is an emergency condition of which reliable epidemiological data are lacking. This study focusses on epidemiology and aetiology of anaphylactic reactions in an urban Belgian emergency department (ED). METHODS Patient data were collected from 04/2009 to 04/2013.During this period, emergency doctors completed a questionnaire for adult patients (>15 years) with anaphylaxis presenting at the ED. Inclusion criteria were based on the Sampson criteria of anaphylaxis. Data were analysed using a Microsoft Excel database. RESULTS Anaphylaxis accounted for 0.04% of all emergency visits in this 4-year period. In both women and men, dyspnoea and urticaria were noted most frequently. 51.7% of cases were possibly elicited by foods, 46.1% by drugs and 3.4% by hymenoptera stings. Women more often reported allergic diseases in their personal history. 55.7% of patients, who had a history of allergy, reported a suspected food-related allergy, 24.6% a drug-related allergy and 8.2% a hymenoptera venom-related allergy. In 76.5% of patients who reported a history of food allergy, food was the presumed elicitor of anaphylaxis. For patients with history of drug allergy, 88.2% had a presumed drug anaphylaxis at the time of presentation at the ED. 81% of cases presented with grade 4 or 5 anaphylaxis. With increasing age, the severity of anaphylaxis increased. Higher tryptase levels correlated with a higher grade of anaphylaxis. CONCLUSION In this Belgian urban population, foods and drugs were by far the most common suspected elicitors of anaphylaxis. Personal history of allergic diseases was present in more than half of the cases.
Collapse
Affiliation(s)
- Y Mostmans
- a Department of Dermatology , Universitair Ziekenhuis Brussel Brussel, Vrije Universiteit Brussel , Belgium
| | - M Blykers
- a Department of Dermatology , Universitair Ziekenhuis Brussel Brussel, Vrije Universiteit Brussel , Belgium
| | - P Mols
- b Service des Urgences et du SMUR, C.H.U. Saint-Pierre , Brussels , Belgium
| | - J Gutermuth
- a Department of Dermatology , Universitair Ziekenhuis Brussel Brussel, Vrije Universiteit Brussel , Belgium
| | - M Grosber
- a Department of Dermatology , Universitair Ziekenhuis Brussel Brussel, Vrije Universiteit Brussel , Belgium
| | - N Naeije
- c Clinic of Immuno-allergology, C.H.U. Brugmann , Brussels , Belgium
| |
Collapse
|
17
|
Desmedt B, Courselle P, De Beer J, Rogiers V, Grosber M, Deconinck E, De Paepe K. Overview of skin whitening agents with an insight into the illegal cosmetic market in Europe. J Eur Acad Dermatol Venereol 2016; 30:943-50. [DOI: 10.1111/jdv.13595] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2015] [Accepted: 12/04/2015] [Indexed: 11/28/2022]
Affiliation(s)
- B. Desmedt
- Division of Food, Medicines and Consumer Safety; Section Medicinal Products; Scientific Institute of Public Health (IPH); Brussels Belgium
- Department of Toxicology, Dermato-Cosmetology and Pharmacognosy; Centre for Pharmaceutical Research (CePhar); Vrije Universiteit Brussel (VUB); Brussels Belgium
| | - P. Courselle
- Division of Food, Medicines and Consumer Safety; Section Medicinal Products; Scientific Institute of Public Health (IPH); Brussels Belgium
| | - J.O. De Beer
- Division of Food, Medicines and Consumer Safety; Section Medicinal Products; Scientific Institute of Public Health (IPH); Brussels Belgium
| | - V. Rogiers
- Department of Toxicology, Dermato-Cosmetology and Pharmacognosy; Centre for Pharmaceutical Research (CePhar); Vrije Universiteit Brussel (VUB); Brussels Belgium
| | - M. Grosber
- Department of Dermatology; Universitair Ziekenhuis Brussel; Vrije Universiteit Brussel (VUB); Brussels Belgium
| | - E. Deconinck
- Division of Food, Medicines and Consumer Safety; Section Medicinal Products; Scientific Institute of Public Health (IPH); Brussels Belgium
| | - K. De Paepe
- Department of Toxicology, Dermato-Cosmetology and Pharmacognosy; Centre for Pharmaceutical Research (CePhar); Vrije Universiteit Brussel (VUB); Brussels Belgium
| |
Collapse
|
18
|
Vandersleyen V, Grosber M, Wilgenhof S, De Kock J, Neyns B, Gutermuth J. Vemurafenib-associated Dupuytren- and Ledderhose palmoplantar fibromatosis in metastatic melanoma patients. J Eur Acad Dermatol Venereol 2015; 30:1133-5. [PMID: 26303964 DOI: 10.1111/jdv.13268] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2015] [Accepted: 05/07/2015] [Indexed: 12/15/2022]
Abstract
BACKGROUND The BRAF-inhibitor vemurafenib, used in patients with metastatic melanoma, induces multiple cutaneous side-effects. OBJECTIVE The aim of this work was to evaluate the development of palmoplantar fibromatosis in a population of patients treated with the BRAF inhibitor vemurafenib. METHODS Between April 2011 and February 2013, we initiated a treatment with vemurafenib in 53 patients with an unresectable stage IIIC or stage IV melanoma. The patients were followed-up on a regular base to monitor possible side-effects. RESULTS A plantar or palmar fibromatosis was observed in five of 53 patients treated with vemurafenib. In four of these patients other risk factors for the development of palmoplantar fibromatosis were absent. CONCLUSION The BRAF-inhibitor vemurafenib might induce palmoplantar fibromatosis.
Collapse
Affiliation(s)
- V Vandersleyen
- Department of Dermatology, Universitair Ziekenhuis Brussel, (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, Brussels, Belgium
| | - M Grosber
- Department of Dermatology, Universitair Ziekenhuis Brussel, (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, Brussels, Belgium
| | - S Wilgenhof
- Department of Medical Oncology, Universitair Ziekenhuis Brussel, (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, Brussels, Belgium
| | - J De Kock
- Department of In Vitro Toxicology and Dermato-Cosmetology, Center for Pharmaceutical Research, Vrije Universiteit Brussel, Brussels, Belgium
| | - B Neyns
- Department of Medical Oncology, Universitair Ziekenhuis Brussel, (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, Brussels, Belgium
| | - J Gutermuth
- Department of Dermatology, Universitair Ziekenhuis Brussel, (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, Brussels, Belgium
| |
Collapse
|
19
|
Ziai M, Cifuentes L, Grosber M, McIntyre M, Prucha H, Ring J, Chen W. Diffuse hair loss associated with hyperprolactinaemia: report of three cases. J Eur Acad Dermatol Venereol 2015; 29:607-8. [PMID: 24612329 DOI: 10.1111/jdv.12407] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- M Ziai
- Department of Dermatology and Allergy, Technische Universität München, Munich, Germany
| | | | | | | | | | | | | |
Collapse
|
20
|
Brockow K, Schallmayer S, Beyer K, Biedermann T, Fischer J, Gebert N, Grosber M, Jakob T, Klimek L, Kugler C, Lange L, Pfaar O, Przybilla B, Rietschel E, Rueff F, Schnadt S, Szczepanski R, Worm M, Kupfer J, Gieler U, Ring J. Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis. Allergy 2015; 70:227-35. [PMID: 25407693 DOI: 10.1111/all.12548] [Citation(s) in RCA: 69] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/13/2014] [Indexed: 11/29/2022]
Abstract
BACKGROUND Structured educational programmes for patients at risk for anaphylaxis have not yet been established. Patients and caregivers often lack adequate skills in managing the disease. METHODS To investigate effects of structured patient education intervention on knowledge, emergency management skills and psychological parameters in patients with previous episodes of anaphylaxis and caregivers of affected children 95 caregivers (11 male, 84 female, mean age 37 years) of affected children and 98 patients (32 male, 66 female, mean age 47.5 years) were randomly assigned to an intervention (IG) or control group (CG) in a multicentre randomized controlled trial. The IG received two 3-h schooling modules of group education; the CG received standard auto-injector training only. Knowledge of anaphylaxis and emergency management competence in a validated training anaphylaxis situation as main outcome measures as well as secondary psychological parameters were assessed at baseline and 3 months after intervention. RESULTS In comparison with controls, the intervention led to significant improvement of knowledge from baseline to 3-month follow-up (caregivers: IG 3.2/13.2 improvement/baseline vs CG 0.7/12.6; P < 0.001; patients: IG 3.9/10.8 vs 1.3/12.6; P < 0.001). Moreover, emergency management competence was increased after intervention as compared to controls (caregivers: IG 8.6/11.2 vs CG 1.2/10.8; P < 0.001; patients: 7.1/11.0 vs 1.1/11.1; P < 0.001). Intervention showed significant reduction of caregiver anxiety (-1.9/8.4 vs -0.7/7.5; P < 0.05). There were no significant changes in the depression scores. CONCLUSION Structured patient education programmes may be beneficial in the management of anaphylaxis by increasing patients' empowerment to prevent and treat the disease.
Collapse
Affiliation(s)
- K. Brockow
- Department of Dermatology und Allergology Biederstein; Technische Universität München; Munich Germany
| | - S. Schallmayer
- Department of Psychosomatics and Psychotherapy; University Hospital Giessen and Marburg; Giessen Germany
| | - K. Beyer
- Department of Paediatric Pneumology and Immunology; Allergy-Center-Charité; Charité Universitätsmedizin Berlin; Berlin Germany
| | - T. Biedermann
- Department of Dermatology; University of Tübingen; Tübingen Germany
| | - J. Fischer
- Department of Dermatology; University of Tübingen; Tübingen Germany
| | - N. Gebert
- Department of Paediatric Pneumology and Immunology; Allergy-Center-Charité; Charité Universitätsmedizin Berlin; Berlin Germany
| | - M. Grosber
- Department of Dermatology und Allergology Biederstein; Technische Universität München; Munich Germany
| | - T. Jakob
- Allergy Research Group; Department of Dermatology; University Medical Center Freiburg; Freiburg Germany
| | - L. Klimek
- Department of Otolaryngology; Center for Rhinology and Allergology Wiesbaden; Mannheim University Hospital; Mannheim Germany
| | - C. Kugler
- Department of Dermatology und Allergology Biederstein; Technische Universität München; Munich Germany
| | - L. Lange
- Division for Pediatrics; St.-Marien-Hospital; Bonn Germany
| | - O. Pfaar
- Department of Otolaryngology; Center for Rhinology and Allergology Wiesbaden; Mannheim University Hospital; Mannheim Germany
| | - B. Przybilla
- Department of Dermatology und Allergology; Ludwig-Maximilians University; Munich Germany
| | - E. Rietschel
- Children's Hospital; University of Cologne; Cologne Germany
| | - F. Rueff
- Department of Dermatology und Allergology; Ludwig-Maximilians University; Munich Germany
| | - S. Schnadt
- German Allergy and Asthma Assiciation; Mönchengladbach Germany
| | | | - M. Worm
- Department of Dermatology and Allergy; Allergy-Center-Charité; Charité Universitätsmedizin Berlin; Berlin Germany
| | - J. Kupfer
- Institute of Medical Psychology; Justus-Liebig-Universität Giessen; Giessen Germany
| | - U. Gieler
- Department of Psychosomatics and Psychotherapy; University Hospital Giessen and Marburg; Giessen Germany
| | - J. Ring
- Department of Dermatology und Allergology Biederstein; Technische Universität München; Munich Germany
| | | |
Collapse
|
21
|
Pierret L, Grosber M, Gutermuth J. Is isotretinoin treatment safe in patients with known peanut allergy? J Eur Acad Dermatol Venereol 2014; 30:140-1. [DOI: 10.1111/jdv.12630] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2014] [Accepted: 06/10/2014] [Indexed: 11/30/2022]
Affiliation(s)
- L. Pierret
- Department of Dermatology; Universitair Ziekenhuis Brussel; Vrije Universiteit Brussel (VUB); Brussels Belgium
| | - M. Grosber
- Department of Dermatology; Universitair Ziekenhuis Brussel; Vrije Universiteit Brussel (VUB); Brussels Belgium
| | - J. Gutermuth
- Department of Dermatology; Universitair Ziekenhuis Brussel; Vrije Universiteit Brussel (VUB); Brussels Belgium
| |
Collapse
|
22
|
Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, Bircher A, Blanca M, Bonadonna B, Campi P, Castro E, Cernadas JR, Chiriac AM, Demoly P, Grosber M, Gooi J, Lombardo C, Mertes PM, Mosbech H, Nasser S, Pagani M, Ring J, Romano A, Scherer K, Schnyder B, Testi S, Torres M, Trautmann A, Terreehorst I. Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013; 68:702-12. [PMID: 23617635 DOI: 10.1111/all.12142] [Citation(s) in RCA: 541] [Impact Index Per Article: 49.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/07/2013] [Indexed: 12/15/2022]
Abstract
Skin tests are of paramount importance for the evaluation of drug hypersensitivity reactions. Drug skin tests are often not carried out because of lack of concise information on specific test concentrations. The diagnosis of drug allergy is often based on history alone, which is an unreliable indicator of true hypersensitivity.To promote and standardize reproducible skin testing with safe and nonirritant drug concentrations in the clinical practice, the European Network and European Academy of Allergy and Clinical Immunology (EAACI) Interest Group on Drug Allergy has performed a literature search on skin test drug concentration in MEDLINE and EMBASE, reviewed and evaluated the literature in five languages using the GRADE system for quality of evidence and strength of recommendation. Where the literature is poor, we have taken into consideration the collective experience of the group.We recommend drug concentration for skin testing aiming to achieve a specificity of at least 95%. It has been possible to recommend specific drug concentration for betalactam antibiotics, perioperative drugs, heparins, platinum salts and radiocontrast media. For many other drugs, there is insufficient evidence to recommend appropriate drug concentration. There is urgent need for multicentre studies designed to establish and validate drug skin test concentration using standard protocols. For most drugs, sensitivity of skin testing is higher in immediate hypersensitivity compared to nonimmediate hypersensitivity.
Collapse
Affiliation(s)
- K. Brockow
- Department of Dermatology und Allergology Biederstein; Division Environmental Dermatology and Allergology Helmholtz Zentrum München/TUM; Technical University Munich; Munich; Germany
| | - L. H. Garvey
- Allergy Clinic; Copenhagen University Hospital; Gentofte; Denmark
| | - W. Aberer
- Department of Dermatology; Medical University of Graz; Graz; Austria
| | | | - A. Barbaud
- Dermatology Department and EA 72-98 INGRES; Brabois Hospital; University Hospital of Nancy; Lorraine University; Vandoeuvre les Nancy; France
| | - M. B. Bilo
- Department of Immunology, Allergy and Respiratory Diseases; Allergy Unit; University Hospital Ospedali Riuniti; Ancona; Italy
| | - A. Bircher
- Dermatologische Universitätsklinik Kantonsspital; Basel; Switzerland
| | - M. Blanca
- Allergy Service; Carlos Haya Hospital; Malaga; Spain
| | - B. Bonadonna
- Allergy Unit; Verona University Hospital; Verona; Italy
| | - P. Campi
- Allergy and Clinical Immunology Unit; San Giovanni di Dio Hospital; Florence; Italy
| | - E. Castro
- Department of Allergy and Clinical Immunology; Medical University; H. S. Joao; Porto; Portugal
| | - J. R. Cernadas
- Department of Allergy and Clinical Immunology; Medical University; H. S. Joao; Porto; Portugal
| | - A. M. Chiriac
- Allergy Department; University Hospital of Montpellier and INSERM U657; Montpellier; France
| | - P. Demoly
- Allergy Department; University Hospital of Montpellier and INSERM U657; Montpellier; France
| | - M. Grosber
- Department of Dermatology und Allergology Biederstein; Division Environmental Dermatology and Allergology Helmholtz Zentrum München/TUM; Technical University Munich; Munich; Germany
| | - J. Gooi
- Department of Immunology; Beaumont Hospital; Dublin; Ireland
| | - C. Lombardo
- Allergy Unit; Verona University Hospital; Verona; Italy
| | - P. M. Mertes
- Service d'anesthésie-réanimation chirurgicale; Hôpitaux Universitaires de Strasbourg; Strasbourg; France
| | - H. Mosbech
- Allergy Clinic; Copenhagen University Hospital; Gentofte; Denmark
| | - S. Nasser
- Department of Allergy; Addenbrooke's Hospital; Cambridge; UK
| | - M. Pagani
- Allergology and Oncology Service; Civil Hospital of Asola; Mantova; Italy
| | - J. Ring
- Department of Dermatology und Allergology Biederstein; Division Environmental Dermatology and Allergology Helmholtz Zentrum München/TUM; Technical University Munich; Munich; Germany
| | - A. Romano
- Allergy Unit; C. I. Columbus; Rome and IRCCS Oasi Maria S. S.; Troina; Italy
| | - K. Scherer
- Dermatologische Universitätsklinik Kantonsspital; Basel; Switzerland
| | - B. Schnyder
- Department of Rheumatology; Clinical Immunology and Allergology; Bern; Switzerland
| | - S. Testi
- Allergy and Clinical Immunology Unit; San Giovanni di Dio Hospital; Florence; Italy
| | - M. Torres
- Allergy Service; Carlos Haya Hospital; Malaga; Spain
| | - A. Trautmann
- Department of Dermatology and Allergology; University of Würzburg; Würzburg; Germany
| | - I. Terreehorst
- Department of ENT and Pediatrics; AMC; Amsterdam; The Netherlands
| | | |
Collapse
|
23
|
Abstract
Among the many attempts to classify urticaria, 2 categories have been accepted worldwide, namely according to time course into acute (shorter than 6 weeks) and chronic urticaria (longer than 6 weeks) and a classification according to etiopathophysiology. A special subgroup is the physical urticarias where wheals are elicited via specific physical (mechanical, temperature, radiation) stimuli. In many forms of chronic urticaria, psychosomatic influences play a role. Despite great progress in modern immunology and allergology, chronic urticaria still remains a challenge for doctors and patients.
Collapse
Affiliation(s)
- J Ring
- Department Dermatology and Allergology Biederstein, Christine Kühne-Center for Allergy Research and Education, Technische Universitaet Muenchen, München, Germany.
| | | |
Collapse
|
24
|
Jaeger J, Andres C, Grosber M, Suarez IL, Zirbs M, Ring J, Brockow K. [Generalized skin change in a newborn infant: infectious, genetic or autoimmune cause? Epidermolytic ichthyosis]. MMW Fortschr Med 2013; 155:5, 72. [PMID: 23614180 DOI: 10.1007/s15006-013-0196-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- J Jaeger
- Klinik und Poliklinik für Dermatologie und Allergologie der Technischen Universität München, Biedersteinter Strasse 29, D-80802 München
| | | | | | | | | | | | | |
Collapse
|
25
|
Pressler A, Grosber M, Halle M, Ring J, Brockow K. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema. Clin Exp Dermatol 2012; 38:151-3. [DOI: 10.1111/j.1365-2230.2012.04430.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
26
|
Aigner B, Darsow U, Grosber M, Ring J, Plötz S. Multiple Basal Cell Carcinomas after Long-Term Exposure to Hydrazine: Case Report and Review of the Literature. Dermatology 2010; 221:300-2. [DOI: 10.1159/000321338] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2010] [Accepted: 09/14/2010] [Indexed: 11/19/2022] Open
|
27
|
Brockow K, Grosber M, Hölzle K, Behrendt H, Ring J. Neues zur Therapie der Mastozytose. Akt Dermatol 2009. [DOI: 10.1055/s-0029-1214736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
28
|
Grosber M, Eberlein B, Engst R, Kerzl R, Manstein P, Ring J, Darsow U, Termeer C, Termeer J, Salmann S, Averbeck M, Simon J, Pfaar O, von Weikersthal-Drachenberg KF, Amersdorffer J, Baumann-Noss S, Woroniecki S, Klimek L, Lauter H, Sager A, Laszczyk M, Scheffler A, Martin S, Kespohl S, Schlünssen V, Jacobsen G, Sigsgaard T, Maryska S, Meurer U, Brüning T, Raulf-Heimsoth M, Riecken S, Lindner B, Petersen A, Jappe U, Becker W, Saloga J, Häringer B, Bellinghausen I, Lafargue B, Decker H, Grabbe S, Baratli J, Asturias J, Hunzelmann N, Kahlert H, Weber B, Cromwell O, Fiebig H, Nandy A, Wald M. Allergene — Allergenträger — Pseudoallergien — Adjuvanzien. Allergo J 2007. [DOI: 10.1007/bf03370606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|